Based on their mechanism of action, these techniques to stimulate ferroptosis may be more effective for BRD4-deficient tumour cells because they can partly compensate for the insensitivity of ferroptosis caused by metabolism disorders due to the lack of BRD4 expression. The gene discussed is BRD4; the disease is metabolic disease.